Cabaletta Bio Inc [NASDAQ: CABA] gained 46.15% on the last trading session, reaching $3.61 price per share at the time.
Cabaletta Bio Inc represents 91.45 million in outstanding shares, while the company has a total market value of $330.19 million with the latest information. CABA stock price has been found in the range of $2.56 to $3.67.
If compared to the average trading volume of 2.84M shares, CABA reached a trading volume of 35636337 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Cabaletta Bio Inc [CABA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CABA shares is $14.12 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CABA stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Jefferies have made an estimate for Cabaletta Bio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 10, 2025. While these analysts kept the previous recommendation, Evercore ISI raised their target price from $15 to $6. The new note on the price target was released on December 20, 2024, representing the official price target for Cabaletta Bio Inc stock. Previously, the target price had yet another drop from $12 to $6, while Wells Fargo kept a Equal Weight rating on CABA stock.
The Price to Book ratio for the last quarter was 1.85, with the Price to Cash per share for the same quarter was set at 2.13.
Trading performance analysis for CABA stock
Cabaletta Bio Inc [CABA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 46.15. With this latest performance, CABA shares gained by 42.69% in over the last four-week period, additionally plugging by 169.40% over the last 6 months – not to mention a rise of 59.03% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CABA stock in for the last two-week period is set at 69.89, with the RSI for the last a single of trading hit 0.37, and the three-weeks RSI is set at 0.30 for Cabaletta Bio Inc [CABA]. The present Moving Average for the last 50 days of trading for this stock 2.23, while it was recorded at 2.82 for the last single week of trading, and 1.87 for the last 200 days.
Cabaletta Bio Inc (CABA) Capital Structure & Debt Analysis
According to recent financial data for Cabaletta Bio Inc. ( CABA), the Return on Equity (ROE) stands at -76.34%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -65.30%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Cabaletta Bio Inc’s Return on Invested Capital (ROIC) is -78.86%, showcasing its effectiveness in deploying capital for earnings.
Cabaletta Bio Inc (CABA) Efficiency & Liquidity Metrics
Based on Cabaletta Bio Inc’s (CABA) latest financial statements, the Debt-to-Equity Ratio is 0.14%, indicating its reliance on debt financing relative to shareholder equity.
Cabaletta Bio Inc (CABA) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Cabaletta Bio Inc. (CABA) effectively leverages its workforce, generating an average of -$896211.18 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.78% and a Quick Ratio of 4.78%, indicating strong ability to cover short-term liabilities.
Cabaletta Bio Inc [CABA]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Cabaletta Bio Inc posted -0.62/share EPS, while the average EPS was predicted by analysts to be reported at -0.61/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CABA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Cabaletta Bio Inc go to 11.63%.
An analysis of Institutional ownership at Cabaletta Bio Inc [CABA]
There are presently around $82.48%, or 83.87%% of CABA stock, in the hands of institutional investors. The top three institutional holders of CABA stocks are: JENNISON ASSOCIATES LLC with ownership of 5.55 million shares, which is approximately 11.2498%. BLACKROCK INC., holding 4.76 million shares of the stock with an approximate value of $$35.58 million in CABA stocks shares; and BLACKROCK INC., currently with $$29.01 million in CABA stock with ownership which is approximately 7.8661%.
